「andmochida pharmaceutical」の検索結果
451件：391～395件目を表示
-
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
sumoto2, Yoshinori Yamagiwa1, Kotaro Yamada1, Hideya Yonekura1, Gen Suzuki1, Ikuyo Atsumi1 1: Senju Pharmaceutical Co., Ltd. 2: Mochida Pharmaceutical Co., Ltd. ARVO 2025 開催日：2025年5月4日～2025年5月8日 開催地：S...
https://www.senju.co.jp/english/rd/society/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
sumoto2, Yoshinori Yamagiwa1, Kotaro Yamada1, Hideya Yonekura1, Gen Suzuki1, Ikuyo Atsumi1 1: Senju Pharmaceutical Co., Ltd. 2: Mochida Pharmaceutical Co., Ltd. ARVO 2025 開催日：2025年5月4日～2025年5月8日 開催地：S...
http://www.senju.co.jp/english/rd/society/ -
发表论文 | 研究与开发 | 千寿制药株式会社
articipants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co., Ltd, Hyogo, Japan. 2: Baylor College of Medicine, Houston, Texas, USA American J...
http://www.senju.co.jp/chinese/rd/thesis/ -
April 6, 2026 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease throug...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
Research and Development System | Research & Development | SENJU Pharmaceutica
ave a reason for being. Today’s common sense is not common sense tomorrow. This is our motto. Senju Pharmaceutical has unique research systems, such as international joint research and industry-academ...
http://www.senju.co.jp/english/rd/about/